This market research report includes a detailed segmentation of the global In Vitro Fertilization market by product (Reagents and Instruments), by cycle type (Fresh IVF Cycles, Thawed IVF Cycles, and Donor IVF Cycles), end-users (Hospitals and Research Laboratories, Fertility and Surgical Centers, and Cryobanks), and by region (North America, EMEA, APAC, and RoW). The market research report identifies Thermo Fisher Scientific Inc., Vitrolife, Cook Medical Inc., Cooper Companies (CopperSurgical Inc.), Irvine Scientific, Genea Limited, OvaScience Inc., Hunter Scientific, EMD Sereno Inc., and ESCO Micro Pte Ltd. as the major vendors operating in the global In Vitro Fertilization market.

Overview of the Global In Vitro Fertilization Market

Infoholic’s market research report predicts that the global In Vitro Fertilization market is expected to grow at a CAGR of 11.2% during the forecast period 2018–2024.

According to the In Vitro Fertilization market industry analysis, Europe accounts for the largest share, followed by North America, Asia Pacific, and Rest of the World. Increasing demand for assisted reproductive technology procedures and smooth implementation of advanced technology makes Europe a dominant shareholder in the market. Whereas, Asia Pacific is the fastest growing market due to increasing fertility tourism, upsurge in awareness, and acceptance of the technology.

In Vitro Fertilization Market Competitive Analysis and Key Vendors

There is an increase in acquisition, collaboration between IVF-related companies, and launching of new IVF products due to the favorable environment for IVF across the globe. For instance, in August 2018, Ferring Pharmaceuticals and Celmatix announced a collaboration, and the primary goal was to uncover new insights into ovarian biology and to accelerate the development of personalized interventions in women health and reproductive medicine. In August 2018, Thomson Medical announced to extend IVF services to China, in collaboration with assisted reproduction specialist IVI-RMA.

The In Vitro Fertilization market is driven by increasing awareness among the public about fertility and accessible treatment options, delayed pregnancies, reducing fertility rates, and initiation from the government to promote IVF treatment. However, high treatment cost, ethical concerns related to IVF, and low success rate of the procedure may slow down the growth of the In Vitro Fertilization market.

Some of the key vendors in the In Vitro Fertilization market are:

• Thermo Fisher Scientific, Inc.


• Vitrolife


• Cook Medical Inc.


• Cooper Companies (CopperSurgical Inc.)


• Irvine Scientific


 

Other prominent vendors are Genea Limited, OvaScience Inc., Hunter Scientific, EMD Sereno, Inc., and ESCO Micro Pte Ltd.

In Vitro Fertilization Market by Product

• Reagents


• Instruments


 

Reagents include embryo culture media, cryopreservation media, sperm processing media, and ovum processing media. Instruments comprise imaging system, sperm separation system, ovum aspiration pump, micromanipulator system, incubators, cryosystems, and others.

In 2017, Instruments segment occupied a significant market share and is expected to grow at a high CAGR during the forecast period.

In Vitro Fertilization Market by Cycle

• Fresh IVF Cycles


• Thawed IVF Cycles


• Donor IVF Cycles


 

In 2017, the Fresh IVF Cycles segment occupied a significant market share and is expected to grow at a high CAGR during the forecast period due to the increased success rate in the first attempt.

In Vitro Fertilization Market by End-users

• Hospitals and Research Laboratories


• Fertility and Surgical Centers


• Cryobanks


 

In 2017, the Fertility and Surgical Centers segment occupied a significant market share in 2017 and is expected to remain the same for the next five years due to the availability of technologically advanced IVF treatment and a broad range of fertility treatment with reimbursement facilities.

In Vitro Fertilization Market Benefits

The report provides detailed information about the usage and adoption of In Vitro Fertilization market in therapeutic verticals and regions. Additionally, key stakeholders can find out the major trends, drivers, investments, vertical player’s initiatives, government and company initiatives toward the adoption of in vitro fertilization in the upcoming years in the market. Moreover, the report provides details about the major challenges that are going to have an impact on market growth. Furthermore, the report gives complete details about the business opportunities to key stakeholders to expand their business and capture revenues in the specific verticals. The report will help companies interested or established in this market to analyze the various aspects of this domain before investing or expanding their business in the In Vitro Fertilization market.

Key Stakeholders

1     Industry Outlook 

1.1        Industry Overview

2     Report Outline 

2.1        Report Scope

2.2        Report Summary

2.3        Research Methodology

2.4        Report Assumptions

3     Market Snapshot 

3.1        Market Definition – Infoholic Research

3.2        Advantages of In Vitro Fertilization

3.3        Disadvantages of In Vitro Fertilization

3.4        Need for In Vitro Fertilization

3.5        Process of In Vitro Fertilization

3.6        Segmented Addressable Market

3.7        Trends in the In Vitro Fertilization Market

3.8        Related Markets

3.8.1     Female Condom Market

3.8.2     Erectile Dysfunction Market

4     Market Outlook 

4.1        History of In Vitro Fertilization

4.2        Market Segmentation

4.3        PEST Analysis

4.4        Porter 5(Five) Forces

5     Market Characteristics 

5.1        Market Dynamics

5.1.1     Drivers

5.1.1.1 Reducing fertility rates

5.1.1.2 Deferred pregnancies among women

5.1.2     Opportunities

5.1.2.1 Initiation from the government to promote IVF treatment

5.1.2.2 Increased fertility tourism

5.1.3     Restraints

5.1.3.1 High cost of IVF treatment

5.1.3.2 Low success rate of IVF treatment

5.2        DRO – Impact Analysis

5.3        Key Stakeholders

6     Products: Market Size and Analysis 

6.1        Overview

6.2        Reagents

6.2.1     Cryopreservation Media

6.2.2     Sperm Processing Media

6.2.3     Embryo Culture Media

6.2.4     Ovum Processing Media

6.3        Instruments

6.3.1     Imaging System

6.3.2     Ovum Aspiration Pumps

6.3.3     Sperm Separation Systems

6.3.4     Micromanipulator Systems

6.3.5     Incubators

6.3.6     Cryosystems

6.3.7     Others

7     Cycle Type: Market Size and Analysis 

7.1        Overview

7.2        Fresh IVF Cycle (Non-donor)

7.3        Thawed IVF Cycle (Non-donor)

7.4        Donor Egg IVF Cycles

8     End-users: Market Size and Analysis 

8.1        Overview

8.2        Hospitals and Research Laboratories

8.3        Fertility and Surgical Centers

8.4        Cryobanks

9     Regions: Market Size and Analysis 

9.1        Overview

9.2        North America

9.3        Europe

9.4        Asia Pacific

9.5        Rest of the World

10  Competitive Landscape 

10.1     Overview

11  Vendors Profile 

11.1     Thermo Fisher Scientific Inc.

11.1.1  Overview

11.1.2  Business Units

11.1.3  Geographic Revenue

11.1.4  Business focus

11.1.5  SWOT Analysis

11.1.6  Business Strategies

11.2     Vitrolife

11.2.1  Overview

11.2.2  Geographic Revenue

11.2.3  Business Focus

11.2.4  SWOT Analysis

11.2.5  Business Strategies

11.3     Cook Medical Inc.

11.3.1  Overview

11.3.2  Business Focus

11.3.3  SWOT Analysis

11.3.4  Business Strategies

11.4     Cooper Companies (CooperSurgical Inc.)

11.4.1  Overview

11.4.2  Business Units

11.4.3  Geographic Revenue

11.4.4  Business Focus

11.4.5  SWOT Analysis

11.4.6  Business Strategies

11.5     Irvine Scientific

11.5.1  Overview

11.5.2  Business Focus

11.5.3  SWOT Analysis

11.5.4  Business Strategies

12  Companies to Watch for 

12.1     Genea Limited

12.1.1  Overview

12.2     EMD Sereno Inc.

12.2.1  Overview

12.3     ESCO Micro Pte Ltd.

12.3.1  Overview

12.4     Hunter Scientific

12.4.1  Overview

12.5     OvaScience Inc.

12.5.1  Overview

12.6     Oxford Gene Technology

12.6.1  Overview

Annexure 

Abbreviations